ruthenium has been researched along with Thrombosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alzahrani, EMS; Attina, A; Gibbins, J; Greco, F; Javed, M; Kabova, E; Osborn, HMI; Pothi, R; Ravishankar, D; Salamah, M; Shankland, K; Strohfeldt, K; Vaiyapuri, R; Vaiyapuri, S; Vallance, TM; Williams, HF | 1 |
| Chang, CC; Chou, DS; Chung, CL; Hsia, CH; Hsia, CW; Jayakumar, T; Khamrang, T; Lin, KC; Sheu, JR; Tsao, SY; Velusamy, M | 1 |
| Hsia, CH; Hsia, CW; Hsu, CY; Jayakumar, T; Khamrang, T; Manubolu, M; Sheu, JR | 1 |
1 review(s) available for ruthenium and Thrombosis
| Article | Year |
|---|---|
Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy.
Topics: Animals; Blood Platelets; Humans; Molecular Targeted Therapy; Organometallic Compounds; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ruthenium; Thrombosis | 2018 |
2 other study(ies) available for ruthenium and Thrombosis
| Article | Year |
|---|---|
Ruthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacy.
Topics: Animals; Biological Availability; Blood Platelets; Disease Models, Animal; Fibrinolytic Agents; Flavonoids; Hemostasis; Humans; Mice; Platelet Activation; Ruthenium; Thrombosis | 2017 |
Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets.
Topics: Blood Platelets; Collagen; Humans; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ruthenium; Ruthenium Compounds; Structure-Activity Relationship; Thrombosis | 2018 |